Founder of Rathbun Communications, Inc., Julie Rathbun presently occupies the position of President at Rathbun Communications, Inc., Head-Public & Investor Relations at Athira Pharma, Inc. and Media Contact at Neoleukin Therapeutics, Inc.

In the past Ms. Rathbun occupied the position of Head-Investor Relations at Sarepta Therapeutics, Inc. and Media Relations Contact at Immune Design Corp.

Ms. Rathbun received an undergraduate degree from Western Washington University.